Miochol-E Related Published Studies
Well-designed clinical trials related to Miochol-E (Acetylcholine)
Dianicline, a novel alpha4beta2 nicotinic acetylcholine receptor partial agonist, for smoking cessation: a randomized placebo-controlled clinical trial. [2011.01]
Nicotinic acetylcholine receptor gene expression is altered in burn patients. [2010.05.01]
Acetylcholine-esterase inhibitor pyridostigmine decreases T cell overactivation in patients infected by HIV. [2009.08]
Quantification of eccrine sweat glands with acetylcholine sweat-spot test and anatomical redistribution of sweating after T2-T3 thoracoscopic sympathicolysis. [2009.02]
Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation. [2008.09.15]
Contribution of the M3 muscarinic receptors to the vasodilator response to acetylcholine in the human forearm vascular bed. [2008.08]
Nicotinic acetylcholine receptor {beta}2 subunit gene implicated in a systems-based candidate gene study of smoking cessation. [2008.07.01]
M2 and M3-muscarinic acetylcholine receptors remodelling in patients with a dilated atrium. [2008.04]
Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers. [2007.06]
A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers. [2007.06]
Effect of ispronicline, a neuronal nicotinic acetylcholine receptor partial agonist, in subjects with age associated memory impairment (AAMI). [2007.03]
Well-designed clinical trials possibly related to Miochol-E (Acetylcholine)
A Prospective, Split-Face, Randomized, Double-Blind Study Comparing
OnabotulinumtoxinA to IncobotulinumtoxinA for Upper Face Wrinkles. [2015]
AZD3480, a novel nicotinic receptor agonist, for the treatment of
attention-deficit/hyperactivity disorder in adults. [2014]
A randomized, double-blind, placebo-controlled phase II study of eculizumab in
patients with refractory generalized myasthenia gravis. [2013]
Cholinergic enhancement of functional networks in older adults with mild
cognitive impairment. [2013]
Effects of 21 days of varenicline versus placebo on smoking behaviors and urges
among non-treatment seeking smokers. [2012]
The quantitative myasthenia gravis score: comparison with clinical,
electrophysiological, and laboratory markers. [2012]
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease
dementia and cognitive impairment in Parkinson's disease. [2012]
Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in
placebo-controlled clinical trials. [2012]
Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder. [2011.12]
A randomized and controlled study comparing immunoadsorption and plasma exchange in myasthenic crisis. [2011.11.17]
Adjunctive Varenicline Treatment with Antipsychotic Medications for Cognitive Impairments in People with Schizophrenia: A Randomized Double-Blind Placebo-Controlled Trial. [2011.11.02]
Memantine in systemic lupus erythematosus: a randomized, double-blind placebo-controlled trial. [2011.10]
Placebo-controlled trial of cytisine for smoking cessation. [2011.09.29]
Mechanistic insights into the therapeutic use of high-dose allopurinol in angina pectoris. [2011.08.16]
Neuromodulatory neurotransmitters influence LTP-like plasticity in human cortex: a pharmaco-TMS study. [2011.08]
A randomized double-blind study comparing 25 and 50 mg TC-1734 (AZD3480) with placebo, in older subjects with age-associated memory impairment. [2011.08]
Effect of pioglitazone on endothelial dysfunction after sirolimus-eluting stent implantation. [2011.07.15]
GDNF levels in the lower lip skin in a rat model of trigeminal neuropathic pain: implications for nonpeptidergic fiber reinnervation and parasympathetic sprouting. [2011.07]
Comparison of IVIg and PLEX in patients with myasthenia gravis. [2011.06.07]
Improving delirium care in the intensive care unit: the design of a pragmatic study. [2011.06.06]
Coronary blood flow in patients with stable coronary artery disease treated long term with folic acid and vitamin B12. [2011.06]
Effects of varenicline on smoking cue-triggered neural and craving responses. [2011.05]
Particle traps prevent adverse vascular and prothrombotic effects of diesel engine exhaust inhalation in men. [2011.04.26]
Single- and multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy Japanese adult smokers. [2011.04]
Single- and multiple-dose pharmacokinetics, safety, and tolerability of the selective alpha7 neuronal nicotinic receptor agonist, ABT-107, in healthy human volunteers. [2011.04]
Pharmacokinetics, safety, and tolerability following multiple oral doses of varenicline under various titration schedules in elderly nonsmokers. [2011.04]
Inhibition of p38 mitogen-activated protein kinase improves nitric oxide-mediated vasodilatation and reduces inflammation in hypercholesterolemia. [2011.02.08]
The bilirubin-increasing drug atazanavir improves endothelial function in patients with type 2 diabetes mellitus. [2011.02]
Why do young women smoke? VI. A controlled study of nicotine effects on attention: pharmacogenetic interactions. [2011.02]
Coadministration of atorvastatin prevents nitroglycerin-induced endothelial dysfunction and nitrate tolerance in healthy humans. [2011.01.04]
Effects of an alpha 7-nicotinic agonist on default network activity in schizophrenia. [2011.01.01]
Effects of short-term anti-inflammatory therapy on endothelial function in patients with non-ST-segment elevation acute coronary syndrome. [2011.01]
[Botulinum toxin and painful peripheral neuropathies: what should be expected?]. [2011.01]
[Botulinum toxin and painful peripheral neuropathies: what should be expected?]. [Article in French] [2011]
Investigation of carbachol and PACAP38 in a human model of migraine. [2010.12]
Daily low-dose folic acid supplementation does not prevent nitroglycerin-induced nitric oxide synthase dysfunction and tolerance: a human in vivo study. [2010.11]
Comparison of the effects of long-acting nifedipine CR and diltiazem R in patients with vasospastic angina: Aomori coronary spastic angina study. [2010.11]
Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease. [2010.10.05]
Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis. [2010.09.07]
Roles of nitric oxide synthase and cyclooxygenase in leg vasodilation and oxygen consumption during prolonged low-intensity exercise in untrained humans. [2010.09]
Vascular reactivity and flow characteristics of radial artery and long saphenous vein coronary bypass grafts: a 5-year follow-up. [2010.08.31]
The interactive effect of acute ovarian suppression and the cholinergic system on visuospatial working memory in young women. [2010.08]
Comparison of selective M3 and nonselective muscarinic receptor antagonists on gastrointestinal transit and bowel habits in humans. [2010.07]
A randomized double-blind study comparing 25 and 50 mg TC-1734 (AZD3480) with placebo, in older subjects with age-associated memory impairment. [2010.06.11]
The sympathetic-vagal balance against endotoxemia. [2010.06]
Effects of estrogen plus progesterone on hemodynamic and vascular reactivity in hypertensive postmenopausal women. [2010.06]
Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients. [2010.06]
Lack of effect of 8 weeks atorvastatin on microvascular endothelial function in patients with systemic sclerosis. [2010.05]
Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failure. [2010.04.27]
Digital assessment of endothelial function and ischemic heart disease in women. [2010.04.20]
Comparing the autoantibody levels and clinical efficacy of double filtration plasmapheresis, immunoadsorption, and intravenous immunoglobulin for the treatment of late-onset myasthenia gravis. [2010.04]
Effects of treatment with once-daily nifedipine CR and twice-daily benidipine on prevention of symptomatic attacks in patients with coronary spastic angina pectoris-Adalat Trial vs Coniel in Tokyo against Coronary Spastic Angina (ATTACK CSA). [2010.03]
Functional magnetic resonance imaging of effects of a nicotinic agonist in schizophrenia. [2010.03]
Green tea catechins improve human forearm endothelial dysfunction and have antiatherosclerotic effects in smokers. [2010.03]
Carbachol induces headache, but not migraine-like attacks, in patients with migraine without aura. [2010.03]
Donepezil treatment and the subjective effects of intravenous cocaine in dependent individuals. [2010.02.01]
Alpha-lipoic acid improves vascular endothelial function in patients with type 2 diabetes: a placebo-controlled randomized trial. [2010.02]
Exposure to nitrogen dioxide is not associated with vascular dysfunction in man. [2010.02]
Tolerance to nitroglycerin-induced preconditioning of the endothelium: a human in vivo study. [2010.02]
Relationship of Q-sweat to quantitative sudomotor axon reflex test (QSART) volumes. [2010.02]
Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial. [2010.01.19]
Sarpogrelate hydrochloride, a selective 5-hydroxytryptamine(2A) antagonist, augments autologous bone marrow mononuclear cell implantation-induced improvement in endothelium-dependent vasodilation in patients with critical limb ischemia. [2010.01]
Long- but not short-term multifactorial intervention with focus on exercise training improves coronary endothelial dysfunction in diabetes mellitus type 2 and coronary artery disease. [2010.01]
Bioequivalence study of two different tablet formulations of donepezil using truncated areas under the curve. A single-center, single-dose, randomized, open-label, 2-way crossover study under fasting conditions. [2010]
Green tea catechins improve human forearm endothelial dysfunction and have antiatherosclerotic effects in smokers. [2010]
The relationship between microvascular endothelial function and carotid-radial pulse wave velocity in patients with mild hypertension. [2010]
Effects of a central cholinesterase inhibitor on reducing falls in Parkinson
disease. [2010]
Long-term administration of endothelin receptor antagonist improves coronary
endothelial function in patients with early atherosclerosis. [2010]
Comparing the autoantibody levels and clinical efficacy of double filtration
plasmapheresis, immunoadsorption, and intravenous immunoglobulin for the
treatment of late-onset myasthenia gravis. [2010]
[Effect of modified huanglian wendan decoction in treating senile patients with
mild cognitive impairment of turbid-phlegm blocking orifice syndrome]. [Article in Chinese] [2010]
Functional magnetic resonance imaging of effects of a nicotinic agonist in
schizophrenia. [2010]
Acute and subacute effect of rheopheresis on microvascular endothelial function in patients suffering from age-related macular degeneration. [2009.12]
Effects of dimethylaminoethanol pyroglutamate (DMAE p-Glu) against memory deficits induced by scopolamine: evidence from preclinical and clinical studies. [2009.12]
Effects of the nicotinic receptor antagonist mecamylamine on ad-lib smoking behavior, topography, and nicotine levels in smokers with and without schizophrenia: a preliminary study. [2009.12]
A randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of ABT-594 in patients with diabetic peripheral neuropathic pain. [2009.12]
Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans. [2009.11]
Effects of insulin and octreotide on memory and growth hormone in Alzheimer's disease. [2009.11]
Botulinum toxin type A reduces histamine-induced itch and vasomotor responses in human skin. [2009.10]
Dopamine genes and nicotine dependence in treatment-seeking and community smokers. [2009.09]
The facilitatory effects of intermittent theta burst stimulation on corticospinal excitability are enhanced by nicotine. [2009.08]
Microvascular endothelial function in obstructive sleep apnea: Impact of continuous positive airway pressure and mandibular advancement. [2009.08]
A randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of ABT-594 in patients with diabetic peripheral neuropathic pain. [2009.07.23]
Varenicline reduces alcohol self-administration in heavy-drinking smokers. [2009.07.15]
Efficacy of rivastigmine for cognitive symptoms in Parkinson disease with dementia. [2009.07]
A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study. [2009.07]
Efficacy of 3,4-diaminopyridine and pyridostigmine in the treatment of Lambert-Eaton myasthenic syndrome: a randomized, double-blind, placebo-controlled, crossover study. [2009.07]
Effect of verapamil, trandolapril and their combination on vascular function and structure in essential hypertensive patients. [2009.07]
Electroencephalographic effects of galantamine in major depressive disorder. [2009.06]
Impaired off-line consolidation of motor memories after combined blockade of cholinergic receptors during REM sleep-rich sleep. [2009.06]
Exercise training improves cutaneous microvascular endothelial function in post-surgical varicose vein patients. [2009.06]
|
